2m 2m 2m 2m 2m 2m 2m
TRAVERE THERAPET (TVTX)
NASDAQ
$55.91+$0.02 (+0.03%)
Price as of Aug 03, 2026 5:52 AM EDT- $5.2BMarket Cap
- 257.58%1-Year Change
- BiotechnologyIndustry
TRAVERE THERAPET (TVTX)
$55.91+$0.02 (+0.03%)
TVTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $55.89 | ||
Change | -$1.39 (-2.43%) | ||
Open | $57.29 | ||
High | $57.55 | ||
Low | $55.30 | ||
Previous Close | $57.28 | ||
Volume | 1,715,029 | ||
30-Day Average Volume | 1,290,728 | ||
1-Week Change | -2.56% | ||
1-Month Change | -1.62% | ||
1-Year Change | 257.58% | ||
3-Year Change | 225.13% | ||
5-Year Change | 306.47% | ||
Fundamentals | |||
Shares Outstanding | 93.0M | ||
Total Assets | $555.2M | ||
Market Cap | $5.2B | ||
Enterprise Value | $5.4B | ||
Period: QTR TTM FY | |||
Revenue | $124.5M | ||
Net Income | -$37.1M | ||
Free Cash Flow | -$40.4M | ||
EBIT | -$35.1M | ||
EBITDA | -$9.9M | ||
Net Working Capital | $267.2M | ||
EPS | -$0.40 | ||
Enterprise Value/EBITDA | -550 | ||
Enterprise Value/Revenue | 44 | ||
P/B | 53 | ||
P/E | -140 | ||
PEG | 0 | ||
Price/Free Cash Flow | -129 | ||
Price/Operating Cash Flow | -129 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue